NYSE:DHR Danaher (DHR) Stock Price, News & Analysis $216.12 +4.31 (+2.03%) As of 03:58 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Danaher Stock (NYSE:DHR) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Danaher alerts:Sign Up Key Stats Today's Range$209.60▼$216.1950-Day Range$179.01▼$219.4252-Week Range$160.93▼$242.80Volume5.00 million shsAverage Volume3.32 million shsMarket Capitalization$151.93 billionP/E Ratio38.39Dividend Yield0.74%Price Target$228.91Consensus RatingModerate Buy Company Overview Danaher Corporation (NYSE:DHR) is a global science and technology company that develops products, services and solutions for the life sciences, biotechnology and diagnostics markets. Its businesses support pharmaceutical and biotechnology research, biomanufacturing, clinical laboratories and healthcare providers. The company’s portfolio includes bioprocessing technologies, laboratory instruments, consumables, reagents and software. Key businesses include Cytiva, which provides biomanufacturing solutions; Beckman Coulter, which supplies laboratory diagnostics and automation systems; Leica Biosystems, which develops pathology products; and IDT, which provides genomic and nucleic acid products. Danaher also owns Pall and Abcam, among other specialized life sciences businesses. Founded in 1969 by Steven and Mitchell Rales, Danaher takes its name from the Danaher Creek in western Montana. The company has expanded through acquisitions and operational improvements and serves customers in North America, Europe, Asia and other international markets. Rainer M. Blair has served as Danaher’s president and chief executive officer since 2020.AI Generated. May Contain Errors. Read More Danaher Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks78th Percentile Overall ScoreDHR MarketRank™: Danaher scored higher than 78% of companies evaluated by MarketBeat, and ranked 103rd out of 895 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.9 / 5Analyst RatingModerate Buy Consensus RatingDanaher has received a consensus rating of Moderate Buy. The company's average rating score is 2.88, and is based on 2 strong buy ratings, 18 buy ratings, 5 hold ratings, and no sell ratings.Upside/DownsideThe consensus price target for Danaher is close to its current price, suggesting limited near-term upside or downside.Amount of Analyst CoverageDanaher has been the subject of 9 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Danaher's stock forecast and price target. Earnings and Valuation2.5 / 5Proj. Earnings Growth8.56% Earnings GrowthEarnings for Danaher are expected to grow by 8.56% in the coming year, from $8.53 to $9.26 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Danaher is 38.39, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 39.05.Price to Earnings Ratio vs. SectorThe P/E ratio of Danaher is 38.39, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 275.56.Price to Earnings Growth RatioDanaher has a PEG Ratio of 2.64. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioDanaher has a P/B Ratio of 2.91. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Danaher's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.54% of the float of Danaher has been sold short.Short Interest Ratio / Days to CoverDanaher has a short interest ratio ("days to cover") of 2.83, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Danaher has recently increased by 9.77%, indicating that investor sentiment is decreasing significantly. Dividend1.7 / 5Dividend StrengthWeak Dividend YieldDanaher has a dividend yield of 0.76%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthDanaher has only been increasing its dividend for 2 years.Dividend CoverageThe dividend payout ratio of Danaher is 28.42%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Danaher will have a dividend payout ratio of 17.28% next year. This indicates that Danaher will be able to sustain or increase its dividend.Read more about Danaher's dividend. News and Social Media3.0 / 5News Sentiment0.87 News SentimentDanaher has a news sentiment score of 0.87. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.54 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 12 news articles for Danaher this week, compared to 8 articles on an average week.Search InterestOnly 13 people have searched for DHR on MarketBeat in the last 30 days. This is a decrease of -24% compared to the previous 30 days.MarketBeat FollowsOnly 11 people have added Danaher to their MarketBeat watchlist in the last 30 days. This is a decrease of -45% compared to the previous 30 days. Company Ownership1.1 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Danaher insiders have not sold or bought any company stock.Percentage Held by Insiders10.80% of the stock of Danaher is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions79.05% of the stock of Danaher is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Danaher's insider trading history. Receive DHR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Danaher and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. DHR Stock News HeadlinesCardinal Health (NYSE:CAH) Vs Danaher Corporation (NYSE:DHR) – Here’s The One Jim Cramer Said Did BetterSeptember 18 at 9:11 PM | insidermonkey.comDanaher (DHR) Could Be 8% Below Fair Value Following Its Dividend ReaffirmationSeptember 16, 2026 | finance.yahoo.comIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially the reasons why we’re bombing the country.September 21 at 1:00 AM | Banyan Hill Publishing (Ad)Danaher declares $0.40 dividendSeptember 16, 2026 | seekingalpha.comDanaher Announces Quarterly DividendSeptember 15, 2026 | prnewswire.comDanaher expands global capability and R&D presence in BengaluruSeptember 12, 2026 | msn.comDanaher, Shopify, MARA: Trending Plays Analysts FavorSeptember 12, 2026 | tipranks.com3 reasons DHR is risky and 1 stock to buy insteadSeptember 10, 2026 | msn.comSee More Headlines DHR Stock Analysis - Frequently Asked Questions How have DHR shares performed this year? Danaher's stock was trading at $228.99 at the beginning of 2026. Since then, DHR stock has decreased by 5.6% and is now trading at $216.12. How were Danaher's earnings last quarter? Danaher Corporation (NYSE:DHR) issued its quarterly earnings data on Monday, July, 20th. The conglomerate reported $1.94 EPS for the quarter, beating analysts' consensus estimates of $1.85 by $0.09. Danaher's revenue for the quarter was up 5.5% on a year-over-year basis. Read the conference call transcript. Does Danaher have any subsidiaries? The following companies are subsidiaries of Danaher: Aldevron, Precision NanoSystems, Aquatic Informatics, Cytiva, GE Biopharma, Integrated DNA Technologies, IDBS Group, and others. Who are Danaher's major shareholders? Danaher's top institutional investors include BlackRock Inc. (7.84%), Wellington Management Group LLP (2.32%), BlackRock Inc. (1.86%) and Jupiter Topco LLC (1.09%). Insiders that own company stock include Steven M Rales, Steven M Rales, Alan G Spoon, Rainer Blair, Joakim Weidemanis, Linda Filler, Daniel Raskas, Matthew Mcgrew, Teri List, Christopher Paul Riley, Brian W Ellis, Walter G Lohr, Gregory M Milosevich and Georgeann Couchara. View institutional ownership trends. How do I buy shares of Danaher? Shares of DHR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Danaher own? Based on aggregate information from My MarketBeat watchlists, some other companies that Danaher investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), UnitedHealth Group (UNH), BlackRock (BLK), JPMorgan Chase & Co. (JPM) and Advanced Micro Devices (AMD). Company Calendar Record date for 7/31 Dividend6/26/2026Ex-Dividend for 7/31 Dividend6/26/2026Last Earnings7/20/2026Dividend Payable7/31/2026Today9/21/2026Record date for 10/30 Dividend9/30/2026Ex-Dividend for 10/30 Dividend9/30/2026Next Earnings (Estimated)10/20/2026Dividend Payable10/30/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (2m+) 1-Year History Sep 25 Dec 25 Mar 26 Jun 26 Sep 26 DHR's financial health is in the Green zone, according to TradeSmith. DHR has been in this zone for over 2 months. Industry, Sector and Symbol Stock ExchangeNYSE SectorHealthcare Industry Life Sciences Tools & Services Sub-IndustryLife Sciences Tools & Services Current SymbolNYSE:DHR CIK313616 Webwww.danaher.com Phone(202) 828-0850Fax202-828-0860Employees60,000Year Founded1984Price Target and Rating Average Price Target for Danaher$228.91 High Price Target$270.00 Low Price Target$195.00 Potential Upside/Downside+5.9%Consensus RatingModerate Buy Rating Score (0-4)2.88 Research Coverage25 Analysts Profitability EPS (Trailing Twelve Months)$5.63 Trailing P/E Ratio38.39 Forward P/E Ratio25.34 P/E Growth2.64Net Income$3.61 billion Net Margins15.95% Pretax Margin18.97% Return on Equity11.04% Return on Assets6.81% Debt Debt-to-Equity Ratio0.48 Current Ratio1.65 Quick Ratio1.25 Sales & Book Value Annual Sales$24.57 billion Price / Sales6.18 Cash Flow$11.60 per share Price / Cash Flow18.63 Book Value$74.38 per share Price / Book2.91Miscellaneous Outstanding Shares702,990,000Free Float627,064,000Market Cap$151.93 billion OptionableOptionable Beta0.78 Social Links 7 Stocks That Could Lead the Next Market BoomTesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.Get This Free Report This page (NYSE:DHR) was last updated on 9/21/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | SponsoredThese gold assets are priced for $1,800 gold [it's over $4,000]Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...Golden Portfolio | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Danaher Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Danaher With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
